Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections

Nicasio Mancini, Lara Marrone, Nicola Clementi, Giuseppe A. Sautto, Massimo Clementi, Roberto Burioni

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Viral infections and opportunistic fungal pathogens represent a major menace for immunocompromised patients. Despite the availability of antifungal and antiviral drugs, mortality in these patients remains high, underlining the need of novel therapeutic options based on completely different strategies. This review describes the potential of several T-cell-based therapeutic approaches in the prophylaxis and treatment of infectious diseases with a particular focus on persistent viral infections and opportunistic fungal infections, as these mostly affect immunocompromised patients.

Original languageEnglish
Pages (from-to)665-682
Number of pages18
JournalFuture Microbiology
Volume10
Issue number4
DOIs
Publication statusPublished - Apr 1 2015

Fingerprint

Mycoses
Opportunistic Infections
Cell- and Tissue-Based Therapy
Immunocompromised Host
Virus Diseases
T-Lymphocytes
Antiviral Agents
Communicable Diseases
Therapeutics
Mortality

Keywords

  • adoptive T-cell therapy
  • chimeric antigen receptor
  • fungal infections
  • immunocompromised patients
  • infectious diseases
  • T cell
  • T-cell receptor
  • viral infections

ASJC Scopus subject areas

  • Microbiology
  • Microbiology (medical)
  • Medicine(all)

Cite this

Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections. / Mancini, Nicasio; Marrone, Lara; Clementi, Nicola; Sautto, Giuseppe A.; Clementi, Massimo; Burioni, Roberto.

In: Future Microbiology, Vol. 10, No. 4, 01.04.2015, p. 665-682.

Research output: Contribution to journalArticle

@article{25009437abd04354b5225691317bf159,
title = "Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections",
abstract = "Viral infections and opportunistic fungal pathogens represent a major menace for immunocompromised patients. Despite the availability of antifungal and antiviral drugs, mortality in these patients remains high, underlining the need of novel therapeutic options based on completely different strategies. This review describes the potential of several T-cell-based therapeutic approaches in the prophylaxis and treatment of infectious diseases with a particular focus on persistent viral infections and opportunistic fungal infections, as these mostly affect immunocompromised patients.",
keywords = "adoptive T-cell therapy, chimeric antigen receptor, fungal infections, immunocompromised patients, infectious diseases, T cell, T-cell receptor, viral infections",
author = "Nicasio Mancini and Lara Marrone and Nicola Clementi and Sautto, {Giuseppe A.} and Massimo Clementi and Roberto Burioni",
year = "2015",
month = "4",
day = "1",
doi = "10.2217/fmb.14.122",
language = "English",
volume = "10",
pages = "665--682",
journal = "Future Microbiology",
issn = "1746-0913",
publisher = "Future Medicine Ltd.",
number = "4",

}

TY - JOUR

T1 - Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections

AU - Mancini, Nicasio

AU - Marrone, Lara

AU - Clementi, Nicola

AU - Sautto, Giuseppe A.

AU - Clementi, Massimo

AU - Burioni, Roberto

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Viral infections and opportunistic fungal pathogens represent a major menace for immunocompromised patients. Despite the availability of antifungal and antiviral drugs, mortality in these patients remains high, underlining the need of novel therapeutic options based on completely different strategies. This review describes the potential of several T-cell-based therapeutic approaches in the prophylaxis and treatment of infectious diseases with a particular focus on persistent viral infections and opportunistic fungal infections, as these mostly affect immunocompromised patients.

AB - Viral infections and opportunistic fungal pathogens represent a major menace for immunocompromised patients. Despite the availability of antifungal and antiviral drugs, mortality in these patients remains high, underlining the need of novel therapeutic options based on completely different strategies. This review describes the potential of several T-cell-based therapeutic approaches in the prophylaxis and treatment of infectious diseases with a particular focus on persistent viral infections and opportunistic fungal infections, as these mostly affect immunocompromised patients.

KW - adoptive T-cell therapy

KW - chimeric antigen receptor

KW - fungal infections

KW - immunocompromised patients

KW - infectious diseases

KW - T cell

KW - T-cell receptor

KW - viral infections

UR - http://www.scopus.com/inward/record.url?scp=84927749704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927749704&partnerID=8YFLogxK

U2 - 10.2217/fmb.14.122

DO - 10.2217/fmb.14.122

M3 - Article

VL - 10

SP - 665

EP - 682

JO - Future Microbiology

JF - Future Microbiology

SN - 1746-0913

IS - 4

ER -